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BK Channels Regulate Contraction Secondary to M2 Muscarinic Acetyl-
choline Receptor Mediated Depolarization
Iurii Semenov, Jeremiah T. Herlihy, Bin Wang, Robert Brenner.
Airway smooth muscles (ASM) contraction is primarily mediated by M2 and
M3 muscarinic acetylcholine receptors. We and others have shown that one
of the functions of large conductance Ca2þ- and voltage-activated (BK) potas-
sium channel and the accessory b1 subunit is to moderate ASM excitation-
contraction coupling by opposing cholinergic evoked depolarization and
reducing activation of L-type voltage-dependent calcium channels. Here, we
have employed airway contraction studies, and a mouse knockout of the BK
channel b1 subunit to investigate fuctional consequences specifically down-
stream of M2 signaling. Our results indicate that effects of BK channels are
downstream of M2 signaling since M2 receptor antagonist (100 nM AF-DX
116) eliminates the enhanced contraction of b1 KO trachea. We found that
the mechanism of M2 antagonist evoked relaxation of b1 KO is a reduction
of excitation-contraction coupling since pretreatment with L-type Ca2þ
channels blocker Nifedipine or with low extracellular potassium solution that
hyperpolarizes membrane potential occludes effect of M2 antagonist. M2 me-
diated membrane depolarization and the role of BK/b1 in controlling ASM
membrane potentials were directly confirmed using sharp electrode recording
of membrane voltage. In summary, these results indicate that the important
role of BK/b1 during M2 activation is to oppose membrane depolarization
and thereby attenuating Ca2þ-influx through voltage dependent Ca2þ-channels.
Blocking M2 signaling largely made BK channels superfluous to control of
ASM contraction.
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Diverse Effects of Alpha1 Adrenoceptor Activation on E-C coupling/CA2þ
Cycling in Canine Atrial Myocytes
Hemantha K. Koduri, Angela Kwiatek, Paloma Pina, Rishi Arora,
Gary Aistrup.
Activation of alpha-adrenoceptors(ARs) by phenylephrine(PE), reportedly pro-
duces both transient negative inotropy and sustained positive inotropy in
ventricles, but only sustained positive inotropy in atria. Differential contribu-
tions of alpha1A- and alpha1B- ARs and coupling to Gq and/or Gi/o proteins
has been invoked to explain such responses. Using Ca2þ fluorescence confocal
microscopy, we have investigated the action PE produces on Ca2þ transients
(CaTs) in canine atrial myocytes. We found that PE (10uM) typically induced
a transient decrease, followed by a sustained increase in CaT peak amplitude
in these myocytes (Fig. 1A)_the CaT decrease was often quite brief, and the
sustained CaT increase was usually accompanied by the development of sub-
cellular CaT alternans. Repeated PE exposure could sometimes induce acute
ablation of CaTs, with occasional large ‘‘escapes’’ (Fig. 1B). Ongoing studies
are focused on elucidating the mechanistic basis for these diverse alpha1-
AR actions using a combination of selective alpha1-AR antagonists and
Galphaq/i/o C-terminal peptides. Findings
should augment understanding of cardiac
alpha1-AR|G-protein coupled signaling,
explain the ineffectiveness/side effects of
present alpha1-AR drugs used in heart fail-
ure and/or ischemic cardiomyopathy, as
well as demonstrate the need for tissue-
specific targeted drug therapy.1570-Pos Board B480
CAMKII Mediates Cardiac Glycoside Toxicity
Luis Gonano, Yanina Rico, Alicia Mattiazzi, Martin Vila Petroff.
The positive inotropic effect produced by inhibition of Naþ/KþATPase (NKA)
with digitalis has been used for the treatment of heart failure (HF) for over 200
years. However, digitalis toxicity-related death in HF patients undermines the
beneficial effect of digitalis treatment. Digitalis-induced Naþ accumulation re-
sults in an increase in Ca2þi via the reverse mode of the Na
þ/Ca2þ exchanger
(NCX) leading to enhanced SR Ca2þ load. The resulting increase in SR Ca2þ
load would then be responsible for the positive inotropic effect and the toxic
arrhythmogenic effects of glycosides. Digitalis-induced increase in Ca2þi could
also activate CaMKII which has been shown to have proarrhythmic effects.
Here we investigate whether CaMKII underlies glycoside arrhythmic effects
and if so, which are the subcellular mechanisms involved. In electrically paced
rat ventricular myocytes (0.5 Hz), 50 mM ouabain increased contraction ampli-
tude by 160 5 5%. Continued exposure to ouabain resulted in spontaneous
contractile activity and Ca2þ waves which persisted even in the absence of
electrical stimulation. Ouabain treatment was associated with activation ofCaMKII (P-CaMKII) and phosphorilation of CaMKII downstream targets,
site Tr17 of phospholamban and site Tr 2815 of the ryanodine receptor
(RyR). Ouabain-induced spontaneous activity was prevented by inhibition of
CaMKII with 1 mMKN93 but not by 1 mMof the inactive analogue KN92. Sim-
ilar results were obtained using the structurally different CaMKII inhibitor, AIP
(1-2.5mM). Ouabain treatment was associated with an increase in SR Ca2þ
content and Ca2þ spark frequency, indicative of enhanced SR Ca2þ leak.
KN93 suppressed the ouabain-induced increase in Ca2þ spark frequency
without affecting SR content. These results suggest that CaMKII mediates
ouabain-induced arrhythmic/toxic effects probably by phophorylating its SR
targets. We speculate that CaMKII mediated phosphorylation of the RyR re-
sulting Ca2þ leak from the SR could be the underlying mechanism involved.
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Erk1-Mediated Development of Left Ventricular Cardiac Hypertrophy
in a P21 Activated Kinase-1 (Pak1) Knockout Mouse Model
Domenico M. Taglieri, Ivana I. Knezevic, Jonathan Chernoff,
R. John Solaro, Yunbo Ke.
Pak1, a serine/threonine protein kinase, plays a critical role in cardiac
excitation-contraction. We hypothesize that Pak1 prevents or attenuates the de-
velopment of left ventricular (LV) cardiac hypertrophy. Six wild-type (WT)
and six Pak1-knockout (KO) mice were randomized into four groups of three
mice each to receive subcutaneously 25mg/g/day of isoproterenol (ISO) or sa-
line (CTRL) for seven days. Transthoracic echocardiography showed in the
Pak1-KO/ISO group vs. WT/ISO group, respectively: i) increased LV frac-
tional shortening (%)(61.655 2.72 vs. 48.025 4.01; p = 0.048); ii) reduced
LV chamber volume (mL) in diastole (36.77 5 4.19 vs. 73.92 5 3.95; p =
0.003) and systole (4.14 50.54 vs. 16.24 5 2.19; p = 0.0058); iii) increased
isoproterenol-induced LV cardiac hypertrophy in Pak1-KOmice (40% increase
in LV mass, p = 0.049) vs. WTmice (15.2 % increase in LV mass, p = 0.07); iv)
enhanced early filling deceleration time (mm/s2) (80460 5 13620 vs.
21550 5 3560; p = 0.014). We also generated novel evidence that Erk1
and Pak1 establish protein-protein interaction in whole cardiac tissue, as as-
sessed by co-immunoprecipitation. Western immunoblotting of Erk1 phosphor-
ylation in whole cardiac tissue showed maximal Erk1 activation in Pak1-KO/
ISO mice vs. all other groups (phosphoErk1/totalErk1 ratio in Pak1-KO/ISO
0.80 5 0.005 vs.: i) WT/CTRL 0.042 5 0.02171, p<0.0001; ii) WT/ISO
0.3086 5 0.0924, p=0.006; iii) Pak1-KO/CTRL 0.6020 5 0.046, p=0.013),
whereas Erk1 phosphorylation was consistently reduced in lysates obtained
from adenovirally-infected adult rat cardiomyocytes that express constitutively
active Pak1 vs. dominant negative Pak1 (phosphoErk1/actin ratio: 7.06% vs.
73.73%, respectively). In conclusion, Pak1-null mice develop LV cardiac
hypertrophy due to increased Erk1 activation, indicating a role for Pak1 as a nat-
ural inhibitor of Erk1 and a novel anti-hypertrophic signaling molecule.
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AAV Mediated Knockdown(KD) of Histidine Rich Calcium Binding Pro-
tein (HRC) Showed Deterioration of Cardiac Function after Transverse
Aortic Constriction-Induced Heart Failure(TAC-HF)
Chang Sik Park, Hye Seon Cha, Mi Young Seo, Woo Jin Park, Do Han Kim.
HRC is a SR luminal protein that binds to both triadin and SERCA, and affects
Ca2þ cycling in the SR (Arvanitis et al. Am. J. Physiol. Heart. Circ. Physiol.
293: H1581, 2007). In the present study, we attempted to characterize the func-
tions of HRC by AAV-mediated KD using TAC-HF model. We expected that
HRC KD could recover cardiac function in failing heart (FH), because HRC
KD by itself could enhance Ca2þ uptake and Ca2þ release by increased activ-
ities of SERCA2 and RyR2 in HL-1 cells. Unexpectedly, AAV9-mediated
HRC KD in TAC-FH showed decreased fractional shortening and increased
cardiac fibrosis compared with control TAC-FH. We found that phospho-
RyR2, phospho-CaMKII, phospho-p38MAPK and phospho-PLB Thr17
were significantly up-regulated in HRC-KD TAC-FH. The cardiac cell
death markers such as LC3A/B and active caspase 9 were also increased, con-
sistent with our results of TUNEL assay. Collectively, the increased cytosolic
Ca2þ level could activate CaMKII and hence phosphorylation of p38MAPK
causing the enhanced mitochondrial death pathway in TAC-FH. Our results
show evidence that down-regulation of HRC is linked to deterioration of cardi-
omyocytes in the pathological state. (Supported by Korea NRF Grant (2010-
0002159), GIST Systems Biology Infrastructure Establishment Grant (2010)
and KISTI-KREONET (2010).
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Calumenin Inhibits Ca2þ Release from Sarcoplasmic Reticulum in Murine
Cardiomyocytes through a Direct Interaction with RyR2
Sanjaya K. Sahoo, In-Ra Seo, Taeyong Kim, Do Han Kim.
Sarcoplasmic reticulum (SR) luminal proteins play an important role in calcium
buffering and in regulation of Ca2þ release. Recently, we showed that
